Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Hikma Pharmaceuticals PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Hikma Pharmaceuticals PLC (HIK-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Aug 2016 Thomson Reuters Stock Report 11 $25.00

"The Economy Matters" Report for HKMPY: the economy's impact on HKMPY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

16 Aug 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Wright Investors Service Comprehensive Report for Hikma Pharmaceuticals PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

13 Aug 2016 Wright Reports 61 $75.00

Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review

Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review Summary Hikma Pharmaceuticals Plc (Hikma Pharm...

08 Aug 2016 GlobalData 110 $300.00

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC - Strategy and SWOT Report, is a source of comprehensive company data and information. The report ...

05 Aug 2016 MarketLine 42 $50.00

HIK.L - Event Transcript of Hikma Pharmaceuticals PLC conference call, Aug. 03, 2016 / 12:45PM ET

Edited Event Transcript of HIK.L conference call, Aug. 03, 2016 / 12:45PM ET Boston, Aug 3, 2016 (Thomson StreetEvents)...

03 Aug 2016 Thomson Reuters StreetEvents 10 $75.00

How Will Hikma Pharmaceuticals Plc Perform Over the Long-Term?

28 Jun 2016 Sadif Analytics Prime 12 $25.00

Company Snapshot - Hikma Pharmaceuticals

A director at Hikma Pharmaceuticals bought 150,000 shares at 2,200p and the significance rating of the trade was 67/100. Is ...

27 Jun 2016 Directors Deals Ltd. 1 $12.00

Hikma Pharmaceuticals Plc: Upgraded to Good

21 Jun 2016 Sadif Analytics Prime 3 $10.00